Valuation: BioElectronics Corporation

Market Cap 1.24Cr 1.08Cr 1Cr 92.33L 1.74Cr 119.2Cr 1.77Cr 12Cr 4.68Cr 58Cr 4.64Cr 4.54Cr 201.48Cr P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 2.57Cr 2.25Cr 2.09Cr 1.92Cr 3.62Cr 247.94Cr 3.67Cr 25Cr 9.75Cr 121.32Cr 9.65Cr 9.44Cr 419.1Cr EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
Manager TitleAgeSince
Chief Executive Officer - 15/11/2019
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member - 15/11/2019
Chairman 85 15/06/2020
Director/Board Member - 03/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%-3.80% - - 74.12L
+0.29%-1.65%+23.11%-7.88% 19TCr
-0.81%-11.43%-6.35%-31.06% 13TCr
-1.93%-11.93%-32.96%+5.87% 12TCr
-0.79%-0.66%-58.55%-18.05% 6.42TCr
+0.10%-3.23%+10.68%-7.60% 4.87TCr
+0.17%-0.52%-24.32%-32.53% 4.38TCr
+1.22%-0.05%+15.89%+5.42% 3.75TCr
+1.07%-0.80%+29.38%+29.60% 3.61TCr
-0.87%-2.27%-27.43%-11.04% 2.82TCr
Average +0.02%-3.15%-7.84%-7.48% 7.81TCr
Weighted average by Cap. -0.35%-3.86%-5.42%-9.55%

Financials

2020 2021
Net sales 8L 7L 7L 6L 11.68L 8Cr 11.86L 80.39L 31.46L 3.92Cr 31.14L 30.47L 14Cr 16.09L 14.1L 13.09L 12.03L 22.67L 16Cr 23L 1.56Cr 61.04L 7.6Cr 60.42L 59.12L 26Cr
Net income -11.6L -10.16L -9L -9L -16.33L -11Cr -16.57L -1.12Cr -43.98L -5.48Cr -43.53L -42.6L -19Cr -3L -3L -2L -2L -4L -2.8Cr -4L -28.08L -10.99L -1.37Cr -10.88L -10.65L -4.73Cr
Net Debt 1.31Cr 1.14Cr 1.06Cr 97.68L 1.84Cr 126.1Cr 1.87Cr 13Cr 4.96Cr 62Cr 4.91Cr 4.8Cr 213.15Cr 1.33Cr 1.17Cr 1.09Cr 99.72L 1.88Cr 128.74Cr 1.91Cr 13Cr 5.06Cr 63Cr 5.01Cr 4.9Cr 217.61Cr
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
-